Old Web
English
Sign In
Acemap
>
authorDetail
>
Carolyn A. Halstead
Carolyn A. Halstead
Eli Lilly and Company
Tabalumab
Biology
Endocrinology
Internal medicine
Keyhole limpet hemocyanin
4
Papers
120
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Fully human anti-BAFF inhibitory monoclonal antibody tabalumab does not adversely affect T-dependent antibody responses in cynomolgus monkey (Macaca fasicularis): A summary of three pre-clinical immunotoxicology evaluations.
2016
Journal of Immunotoxicology
Wendy J. Komocsar
Jamie L. Blackbourne
Carolyn A. Halstead
Colleen J. Winstead
Daniel Wierda
Show All
Source
Cite
Save
Citations (3)
Developmental Toxicity and Fertility Assessment in Rabbits with Tabalumab: A Human IgG4 Monoclonal Antibody.
2015
Birth Defects Research Part B-developmental and Reproductive Toxicology
William J. Breslin
Kim G. Hilbish
Jennifer A. Martin
Carolyn A. Halstead
Tammy L. Edwards
Show All
Source
Cite
Save
Citations (4)
An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody
2015
Birth Defects Research Part B-developmental and Reproductive Toxicology
William J. Breslin
Kim G. Hilbish
Jennifer A. Martin
Carolyn A. Halstead
Deanna L. Newcomb
Gary J. Chellman
Show All
Source
Cite
Save
Citations (4)
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys.
2013
PLOS ONE
Andrew C. Adams
Carolyn A. Halstead
Barbara C. Hansen
Armando R. Irizarry
Jennifer A. Martin
Sharon R. Myers
Vincent L. Reynolds
Holly W. Smith
Victor J. Wroblewski
Alexei Kharitonenkov
Show All
Source
Cite
Save
Citations (109)
1